Safety and Efficacy of ESWL for Geriatric Patients With Chronic Pancreatitis

NCT03373682 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1404

Last updated 2017-12-14

No results posted yet for this study

Summary

Pancreatic extracorporeal shock wave lithotripsy (P-ESWL) is recommended as the first-line treatment for pancreatic stones. However, how well P-ESWL performs in geriatric patients remains unclear. The investigators aimed to evaluate the safety and efficacy of P-ESWL for geriatric patients with chronic pancreatitis.

Conditions

  • Chronic Pancreatitis
  • Geriatric
  • Extracorporeal Shock Wave Lithotripsy

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2016-04-30
Completion
2018-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03373682 on ClinicalTrials.gov